Aspergillus niger keratoconjunctivitis.
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D006801:Humans; D007637:Keratoconjunctivitis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D008875:Middle Aged
D000935:Antifungal Agents; D000666:Amphotericin B